UPDATED
Reporting of clinical trial results is ‘poor and not improving’
A study on the disclosure of the results of clinical trials found that a majority did not meet the publication deadline, with non-industry most likely to fail to publish.
UPDATED
A study on the disclosure of the results of clinical trials found that a majority did not meet the publication deadline, with non-industry most likely to fail to publish.
Covance wants to translate its success at winning early-phase trials into more late-phase business.
Takeda tasks Charles River with sorting through “plethora” of early stage assets.